Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|June 28, 2008
[Carcinoma of unknown primary site (CUP syndrome)]A Sendler, D Strumberg, A TannapfelBiochimica Et Biophysica Acta|September 28, 1998
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzymeY Pommier, P Pourquier, Y Fan, et al.Onkologie|February 5, 2003
The Ras-Raf-MEK-ERK pathway in the treatment of cancerR A Hilger, M E Scheulen, D StrumbergAnti-Cancer Drugs|June 23, 1998
Paclitaxel plus ifosfamide in advanced ovarian cancer: results of a phase I studyU Klaassen, A Harstrick, D Strumberg, et al.Anti-Cancer Drugs|June 1, 1996
Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell linesD Strumberg, A Harstrick, K Doll, et al.European Journal of Pediatrics|November 1, 1992
Molecular detection of genetic defects in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a study of 27 familiesD Strumberg, B P Hauffa, B Horsthemke, et al.Nucleic Acids Research|October 10, 1997
In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cellsC Pondarré, D Strumberg, A Fujimori, et al.Journal of Medicinal Chemistry|February 13, 1999
Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisonsD Strumberg, Y Pommier, K Paull, et al.European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancerU Klaassen, H Wilke, D Strumberg, et al.Pageof 5